Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update.

Nieken, J

Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update. [electronic resource] - Cancer biotherapy & radiopharmaceuticals Oct 1996 - 289-95 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

1084-9785

10.1089/cbr.1996.11.289 doi


Adult
Aged
Carcinoma, Renal Cell--mortality
Female
Humans
Injections, Subcutaneous
Interleukin-2--administration & dosage
Kidney Neoplasms--mortality
Male
Middle Aged
Outpatients
Survival Rate